Drug Profile
MBI 853NL
Latest Information Update: 20 Jul 2001
Price :
$50
*
At a glance
- Originator MIGENIX
- Class Antibacterials
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Staphylococcal infections